CRIVOSIN 1 mg (VINCRISTINE)
- Where we areCL 86A BIS 15 22, CHAPINERO, BOGOTÁ
- Advice on WhatsAppMessage us at +573172701347
Description
* Visual reference image to avoid errors in purchasing and dispensing.
CRIVOSIN is useful as part of several therapeutic regimens due to its relative lack of hematological toxicity. The main indication for CRIVOSIN is the treatment of acute leukemia in combination with other medicines. It is recommended in the treatment of disseminated Hodgkin lymphoma, as well as for the palliative treatment of advanced non-Hodgkin lymphomas. CRIVOSIN is also used in regimens for the palliative treatment of neuroblastoma. Other indications for CRIVOSIN are: miscellaneous sarcomas, small cell lung carcinoma, osteogenic sarcoma, Ewing's sarcoma, Burkitt's lymphoma, cerebral medulloblastoma, multiple myeloma, renal carcinomas and Kaposi's sarcoma in patients with AIDS.
CRIVOSIN is also used in combination with other oncolytics in rhabdomyosarcoma and Wilms
tumor. In some cases it has been used in the treatment of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.
IT IS A MEDICINE. DO NOT EXCEED THE RECOMMENDED USE. READ THE INDICATIONS AND CONTRAINDICATIONS. IF SYMPTOMS PERSIST, CONSULT A DOCTOR.
IMPORTANT - REFRIGERATED MEDICINE: STABILITY MUST BE GUARANTEED WITH THE APPROPRIATE RESOURCES